Showing 1 - 2 results of 2 for search 'Harm Haak', query time: 0.02s Refine Results
  1. 1
    Comparison of SIRS criteria and qSOFA score for identifying culture-positive sepsis in the emergency department: a prospective cross-sectional multicentre study

    Comparison of SIRS criteria and qSOFA score for identifying culture-positive sepsis in the emergency department: a prospective cross-sectional multicentre study by Lisette Mignot-Evers, Vivian Raaijmakers, Gerba Buunk, Steffie Brouns, Lorenzo Romano, Thijs van Herpt, Arvind Gharbharan, Jeanne Dieleman, Harm Haak

    Published 2021-06-01
    Get full text
    Article
  2. 2
    630 EO2401, a new peptide immunotherapy against cancer, in combination with nivolumab, induces a strong and durable immune response in patients from the EOADR1–19/SPENCER study

    630 EO2401, a new peptide immunotherapy against cancer, in combination with nivolumab, induces a strong and durable immune response in patients from the EOADR1–19/SPENCER study by Salvatore Grisanti, Vivek Subbiah, Eric Baudin, Gedske Daugaard, Alfredo Berruti, Jennifer Martinez, Camilo Jimenez, Harm Haak, Jerome Kervevan, Lucie Aubergeon, Chloé Ventujol, Christophe Bonny, Laurent Chene, Joao Gamelas Magalhaes, CWillemien Menke-vander Houven van Oordt, Martin Fassnacht, Jaume Capdevila, Christelle de la Fouchardière, Dan Granberg, Matthias Kroiss, Hélène Toussaint, Camille Belyn, Jean-Michel Paillarse

    Published 2023-11-01
    Article

Search Tools: